Search

Displaying results 3231 - 3240 of 10000 in total
  1. Drug

    GALE-301

    go.drugbank.com/drugs/DB17262
    Investigational

    It is made up of E39, an immunogenic peptide derived from the folate binding protein (FBP), and an immune adjuvant, granulocyte macrophage-colony stimulating factor (GM-CSF).[A254696,L44166,L44171]

  2. Drug

    RPI-MN

    go.drugbank.com/drugs/DB17957
    Experimental

    RPI-MN is a detoxified or chemically modified alpha-cobratoxin with antiviral properties. … [A260132] Being developed by Nutra Pharma under the trade name PEPTERON, it is being investigated for the treatment of neurological and immune disorders.[L47107]

    Synonyms: RPI-MN
  3. Drug

    Baxdrostat

    go.drugbank.com/drugs/DB19090
    ApprovedInvestigational

    It targets aldosterone excess, a primary underlying driver of treatment resistance and organ damage in cardiovascular diseases [A275512, A275515].

  4. Drug

    Ethylhexyl methoxycrylene

    go.drugbank.com/drugs/DB11226
    Approved

    It currently enjoys regional approvals in Canada, the EU, and the US [L2847]. … It returns UV filters to their ground states without absorbing sunlight [F104].

  5. Drug

    Formestane

    go.drugbank.com/drugs/DB08905
    ApprovedWithdrawn

    Formestane has poor oral bioavailability, and thus must be administered fortnightly (bi-weekly) by intramuscular injection. … It is listed as a prohibited substance by the World Anti-Doping Agency for use in athletes.

  6. Drug

    Stearic acid

    go.drugbank.com/drugs/DB03193
    Approved

    It is a waxy solid.

    Mixtures: Huile D'onagre Vitamin E, O Hui Veil Fit Dual Foundation 20Products: G Pore Deep Clearing Foam
  7. Drug

    Berotralstat

    go.drugbank.com/drugs/DB15982
    ApprovedInvestigational

    [A225106] Berotralstat was first approved by the FDA on December 3, 2020, as the first once-daily oral therapy to prevent angioedema attacks of HAE in adults and pediatric patients 12 years and older. … [L26661] It works by blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE.

  8. Drug

    Droxidopa

    go.drugbank.com/drugs/DB06262
    ApprovedInvestigational

    Provided L-DOPS successfully completes clinical trials, it could be approved for the treatment of neurogenic orthostatic hypotension (NOH) as early as 2011. … Though L-DOPS has been used in Japan and Southeast Asia already for some time, it is also currently in clinical trials at the phase III point in the United States (U.S.), Canada, Australia, and throughout

    Synonyms: L-DOPS, L-Dihydroxyphenylserine
  9. Drug

    Osilodrostat

    go.drugbank.com/drugs/DB11837
    ApprovedInvestigational

    [A191850] Osilodrostat was approved for use in the EU in January 2020 for the treatment of endogenous Cushing's syndrome (i.e. … Cushing's disease),[A191850] and was granted FDA approval and Orphan Drug designation in the US in March 2020 for the same indication.[L12162]

  10. Drug

    Benzethonium

    go.drugbank.com/drugs/DB11125
    Approved

    It is shown to be effective in mediating its antimicrobial action against bacteria, fungi, mold and viruses. … It is additionally found in cosmetics and toiletries such as mouthwashes and anti-itch ointments.

    Mixtures: Sanitary Wet Wipes, Disinfectant Wet WipesProducts: Hand-E-foam, Hand-Giene E-2